Trump's Tariffs: Impact on Intellectual Property, including Pharmaceuticals & Semiconductors/Microchips

By Paul Logothetis

Media Relations Advisor, uOttawa

Semiconductors
Maxence Pira (Unsplash)
Academic experts available to comment on:

Trump's Tariffs: Impact on Intellectual Property, including Pharmaceuticals & Semiconductors/Microchips

Members of the media may directly contact the following experts on this topic:


Jeremy de Beer (English only)

Full Professor, Faculty of Law - Common Law Section and Canada Research Chair in Innovation and Intellectual Property Law

[email protected]

Professor Jeremy de Beer is a globally recognized thought leader in the fields of intellectual property, technology innovation, and international trade and development whose research spans the disciplines of law, business, political science, international relations, and public policy.

" Donald Trump’s fickle reprieve on certain reciprocal tariffs and direction to investigate trade in pharmaceuticals and semiconductors should force people to think more about intellectual property issues. What the U.S. lacks in capacity to manufacture these goods it more than makes up for in ownership of patents and other intellectual property rights. Threatening other countries’ industries puts America’s ownership of ideas at risk for retaliation."

"Most people are talking about the trade war in terms of impacts on goods. But that's the economy of the past not the future. And it ignores the real economic stakes for the US and other countries that want to build an economy on ideas not objects."